CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $18,634,000 | +4.6% | 202,630 | 0.0% | 0.17% | +10.3% |
| Q2 2015 | $17,807,000 | +18.4% | 202,630 | 0.0% | 0.16% | +24.8% |
| Q1 2015 | $15,041,000 | +32.6% | 202,630 | 0.0% | 0.12% | +7.8% |
| Q4 2014 | $11,347,000 | -65.5% | 202,630 | -74.5% | 0.12% | -71.1% |
| Q2 2014 | $32,847,000 | -10.5% | 793,221 | +49.7% | 0.40% | -13.9% |
| Q1 2014 | $36,712,000 | +14.8% | 529,990 | -0.1% | 0.47% | +3.5% |
| Q4 2013 | $31,988,000 | +74.4% | 530,738 | +75.9% | 0.45% | +72.8% |
| Q3 2013 | $18,346,000 | -47.8% | 301,744 | -42.5% | 0.26% | -62.5% |
| Q2 2013 | $35,172,000 | – | 525,113 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |